enspryng
roche registration gmbh - satralizumab - neuromyelitis optica - immunszuppresszánsok - satralizumab (enspryng) is indicated as a monotherapy or in combination with immunosuppressive therapy (ist) for the treatment of neuromyelitis optica spectrum disorders (nmosd) in adult and adolescent patients from 12 years of age who are anti-aquaporin-4 igg (aqp4-igg) seropositive.
datura stramonium (stramonium) golyócskák (c 5)
boiron -
datura stramonium (stramonium) golyócskák (c 12)
boiron -
datura stramonium (stramonium) golyócskák (c 15)
boiron -
datura stramonium (stramonium) golyócskák (c200)
boiron -
datura stramonium (stramonium) golyócskák (c 30)
boiron -
datura stramonium (stramonium) golyócskák (c 6)
boiron -
datura stramonium (stramonium) golyócskák (c 9)
boiron -
datura stramonium (stramonium) golyócskák (c 2)
boiron -
rayvow
eli lilly nederland b.v. - lasmiditan succinate - migrénes betegségek - fájdalomcsillapítók - rayvow is indicated for the acute treatment of the headache phase of migraine attacks, with or without aura in adults.